ACW News 5.09 06/04/2014 04:23:19 Accuride Corporation (ACW)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Accuride Corporation (ACW) 5.09 $ACW

NYSE stocks posting largest percentage decreases
AP - Tue Jun 03, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:

29.1% Return Seen to Date on SmarTrend Accuride Call (ACW)
Comtex SmarTrend(R) - Tue Jun 03, 9:41AM CDT
SmarTrend identified an Uptrend for Accuride (NASDAQ:ACW) on January 7th, 2014 at $4.11. In approximately 5 months, Accuride has returned 29.11% as of today's recent price of $5.30.

Photo Release -- Accuride's New Accu-Flange(TM) Aluminum Wheels Fight Flange Wear
GlobeNewswire - Mon Jun 02, 8:33AM CDT
-- Accu-Flange(TM) features a protective surface treatment that reduces rim flange wear

Should Accuride (ACW) Be On Your Radar Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 30, 7:38AM CDT
Accuride (ACW) looks well positioned for a solid gain, but has been overlooked by investors lately. This Auto Parts stock has actually seen estimates rise over the past month for the current fiscal year by about 53.3%.

Accuride Has Returned 39.6% Since SmarTrend Recommendation (ACW)
Comtex SmarTrend(R) - Tue May 27, 9:09AM CDT
SmarTrend identified an Uptrend for Accuride (NASDAQ:ACW) on January 7th, 2014 at $4.11. In approximately 5 months, Accuride has returned 39.59% as of today's recent price of $5.73.

What Makes Spartan Motors (SPAR) a Strong Sell? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 22, 7:45AM CDT
It may be a good decision to sell Spartan Motors's as its price dropped significantly in the past four weeks, the stock witnessed a negative trend in earnings estimate revisions and a Zacks Rank #5 confirms weakness.

Accuride Erie Facility Reaches New Collective Bargaining Agreement
GlobeNewswire - Wed May 21, 3:45PM CDT
-- Agreement lends stability, solidifies competitiveness for the advanced aluminum wheel facility

34.2% Return Seen to Date on SmarTrend Accuride Call (ACW)
Comtex SmarTrend(R) - Mon May 19, 4:42PM CDT
SmarTrend identified an Uptrend for Accuride (NASDAQ:ACW) on January 7th, 2014 at $4.11. In approximately 4 months, Accuride has returned 34.23% as of today's recent price of $5.51.

Strength Seen in SORL Auto Parts (SORL): Stock Soars 20.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 19, 7:51AM CDT
SORL Auto Parts, Inc. (SORL) was a big mover last session, as the company saw its shares rise nearly 21% on the day.

Accuride to Webcast B. Riley & Co. Conference Presentation
GlobeNewswire - Tue May 13, 8:15AM CDT
Accuride Corporation (NYSE:ACW) - a leading supplier of components to the North American commercial vehicle industry - today announced that it will webcast its investor meeting presentation on Tuesday, May 20, 2014 at the 15th Annual B. Riley & Co. Investor Conference being held at Loews Santa Monica Beach Hotel in Santa Monica, Calif.

Uptrend Call Working As Accuride Stock Rises 35.0% (ACW)
Comtex SmarTrend(R) - Mon May 12, 12:13PM CDT
SmarTrend identified an Uptrend for Accuride (NASDAQ:ACW) on January 7th, 2014 at $4.11. In approximately 4 months, Accuride has returned 34.96% as of today's recent price of $5.54.

Why Accuride Corp. (ACW) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 12, 7:47AM CDT
Accuride Corp. (ACW), a commercial vehicle components manufacturer, could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

Can the Uptrend Continue for Accuride (ACW)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue May 06, 8:16AM CDT
Can the Uptrend Continue for Accuride (ACW)?

Accuride Shares Up 33.3% Since SmarTrend's Buy Recommendation (ACW)
Comtex SmarTrend(R) - Mon May 05, 9:36AM CDT
SmarTrend identified an Uptrend for Accuride (NASDAQ:ACW) on January 7th, 2014 at $4.11. In approximately 4 months, Accuride has returned 33.25% as of today's recent price of $5.47.

Accuride Corp. (ACW) in Focus: Stock Moves 5.2% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 01, 8:18AM CDT
Accuride Corp. (ACW) was a big mover last session, as the company saw its shares rise by over 5% on the day.

NYSE stocks posting largest volume increases
AP - Tue Apr 29, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:

Upgrade Alert for Accuride (ACW)
Comtex SmarTrend(R) - Tue Apr 29, 7:56AM CDT
Accuride (NASDAQ:ACW) was upgraded from Fair Value to Buy at CRT Capital today. The stock closed yesterday at $4.97 on volume of 1.2 million shares, above average daily volume of 196,000. Accuride Corp. manufactures and supplies commercial vehicle components in North America. The Company's products include commercial vehicle wheels, wheel-end components and assemblies, truck body and chassis parts, seating assemblies and other commercial vehicle components.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 3

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 2

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 2

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 2

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 7

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 4

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Discovering High-Yield Dividend Opportunities Today

Updated Category News Views 46

Ares Capital got traders buzzing back when it offered a solid yield of around 9%. It stood out as the largest publicly traded business development company (BDC) globally, which made income-focused investors take notice. But here’s the kicker: BDCs like Ares can sidestep corporate taxes if they hand out most of their earnings as dividends, creating a prime hunting ground...

Continue Reading
Anthony DiSilvestro Joins Keurig Dr Pepper as CFO

Updated Category News Views 175

Keurig Dr Pepper Welcomes New Chief Financial Officer Keurig Dr Pepper (NASDAQ: KDP) recently announced an exciting leadership change with the appointment of Anthony DiSilvestro as its new Chief Financial Officer. This important transition marks a significant step as DiSilvestro steps into his role immediately, bringing over four decades of extensive experience across...

Continue Reading
Elisa's New Branding: Introducing Elisa Industriq for Growth

Updated Category News Views 237

Elisa Unveils Elisa Industriq: A New Era in Software Solutions Elisa Oyj is excited to announce a significant milestone as it consolidates its international digital services under a unified brand known as Elisa Industriq. This initiative aims to streamline its software offerings and create a robust identity within the market. Following this change, Elisa will report the...

Continue Reading
Illinois American Water Backs United Way with Grants

Updated Category News Views 15

Driving Community Support Through Strategic Grants The American Water Charitable Foundation and Illinois American Water are making waves by putting their money where their mouth is, delivering a batch of state strategic impact grants to United Way organizations that promise to spark some serious change. It’s not every day you see such a duo diving into local communities...

Continue Reading
Essity Faces Early Bond Repayment Demand Amid Dispute

Updated Category News Views 43

Essity Faces Early Bond Repayment Demand Amid Dispute Essity has found itself in a challenging situation. Recently, a handful of bondholders have made a demand for the early repayment of bonds that are set to mature in the upcoming years of 2029, 2030, and 2031. This unexpected request has prompted Essity to reaffirm its position and contest the claims of these...

Continue Reading